Cencora OUTPH Insights

  1. How To Effectively Manage Local Affiliate Pharmacovigilance Outsourcing 5/12/2026

    Managing PV across dozens of markets strains even experienced safety teams. Learn about a framework that helps you maintain compliance, reduce risk, and scale confidently into new markets.

  2. Mid-Sized Pharma Optimizes Local Affiliate Safety Operations 5/12/2026

    Managing local affiliate PV strains any team. See how a mid-sized biopharma standardized ICSR processing across 94 countries, improved compliance tracking, and achieved centralized oversight.

  3. When CGT Supply Chains Break Down: 5 Operational Gaps That Put Patient Outcomes At Risk 4/22/2026

    Examine five of the most consequential gaps in CGT supply chain performance and learn what high-functioning teams do differently to protect patient outcomes before a failure occurs.

  4. Addressing A Critical Drug Shortage 4/20/2026

    A critical drug shortage demanded regulatory action, importation support, and patient program readiness. See how integrated QA, 3PL, and PSP capabilities delivered operational readiness in three months.

  5. Foreign Action Notification To Health Canada 4/20/2026

    Health Canada is tightening foreign action reporting expectations. MAHs need to understand what the updated draft guidance means for their compliance and monitoring processes now.

  6. Specialist PV Support Transforms Safety For Orphan Medicinal Products 4/17/2026

    Learn how a UK-based company developing two orphan-designated, centrally authorized therapies successfully navigated operational challenges after transitioning from a prior provider.

  7. Boosting Quality And Reducing Complexity With A Single-Provider PV Solution 4/17/2026

    Discover how a German biopharmaceutical company successfully managed growing global pharmacovigilance complexity across more than 2,300 marketing authorizations and a broad partner network.

  8. International Reference Pricing (IRP): Foundations, Shifts, And What To Do Next 4/17/2026

    As global pricing reforms evolve and policies gain traction, stakeholders must critically reassess the role of International Reference Pricing in balancing affordability, access, and incentives for innovation.

  9. Streamlining European Expansion With Integrated PV, Regulatory, And Commercial Expertise 4/17/2026

    See how a single-provider model integrated pharmacovigilance with regulatory and commercialization support to support a scalable, audit-ready system that strengthened compliance and freed internal resources for growth.

  10. How Automation, Analytics, And AI Can Assist Safety Signal Management 3/4/2026

    See how advanced analytics and human-in-the-loop systems are helping safety teams move beyond traditional disproportionality methods to manage complex biologics and growing case volumes.